GRAIL, Inc. Cash and Cash Equivalents
GRAIL, Inc. (GRAL) had Cash and Cash Equivalents of $55.65 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-06
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $55.65M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $69.34M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $249.73M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $126.89M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $55.65M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $69.34M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $249.73M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $126.89M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $127.43M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $133.90M 10-Q · filed 2026-05-07 |
| 2024-12-31 | $214.23M 10-K · filed 2026-03-12 |
| 2024-09-30 | $853.55M 10-Q · filed 2025-11-13 |
| 2024-06-30 | $958.85M 10-Q · filed 2025-08-13 |
| 2024-03-31 | $199.72M 10-Q · filed 2025-05-14 |
| 2023-12-31 | $97.29M 10-K · filed 2026-03-12 |
| 2023-10-01 | $143.84M 10-Q · filed 2024-11-13 |
| 2023-06-30 | $230.62M 10-Q · filed 2024-08-13 |
| 2023-01-01 | $241.60M 10-K · filed 2025-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |